International Journal of Clinical Pharmacy

, Volume 33, Issue 1, pp 20–24 | Cite as

Review of paediatric gastrointestinal physiology data relevant to oral drug delivery

Review Article

Abstract

Aim of the Review relatively new European Union regulations on children’s medicines have emphasised the need for scientists to consider paediatric populations during drug development. This requires an understanding of the physiology in the paediatric population compared to that of adults. In this review, data cited in the public literature on the gastrointestinal (GI) physiology that could affect drug absorption have been summarised to draw attention to some of the differences between adults and paediatric populations that can make predicting the pharmacokinetics of oral drugs in the paediatric population a complex task. Method a search for relevant articles was conducted using EMBASE, MEDLINE (through PubMed) and The National Institute for Public Health and the Environment. Additional journals were found from the references in the initial search results. Furthermore, a selection of common textbooks was used to fill in gaps in physiology data or understanding not covered by the journal articles found. Only data obtained from healthy individuals was used. Results information on the pH and transit time along the GI tract, as well as other GI physiology data was collated and summarised. There was less data available in the literature on the younger population partly as a consequence of the challenging ethics of carrying out invasive tests on healthy children. Discussion and Conclusion it was found that considerable variability in physiology exists within the paediatric population. The pH and transit time of the GI tract varies with age, with the greatest changes occurring during the neonate’s first month. Other GI physiology also varies with age potentially having an impact on drug absorption. This review highlights the variability of paediatric physiological values within the literature, indicating the difficulty in performing measurements in the paediatric population as well as the natural variability that exists in this age group.

Keywords

Absorption Colon Drug Gastrointestinal tract Paediatrics (pediatrics) Physiology Small intestine 

Abbreviations

GI

Gastrointestinal

EMEA

European Medicines Agency

SMA

Superior Mesenteric Artery

Notes

Acknowledgments

The author would like to thank Dr John Hempenstall, Joanne Heafield and Terry Ernest for their continual support and comments on earlier versions of this paper.

Funding

This literature review was carried out as part of paediatric research work funded by GlaxoSmithKline.

Conflicts of interest

The author is a full-time employee of GlaxoSmithKline as a Formulation Scientist working in Product Development. In the opinion of the author this role is not relevant to this paper, with no conflicts of interests to declare.

References

  1. 1.
    Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000;320:79–82.PubMedCrossRefGoogle Scholar
  2. 2.
    Breitkreutz J. European perspectives on pediatric formulations. Clin Ther. 2008;30:2146–54.PubMedCrossRefGoogle Scholar
  3. 3.
    Dunne J. The European regulation on medicines for paediatric use. Paediatr Respir Rev. 2007;8:177–83.PubMedCrossRefGoogle Scholar
  4. 4.
    Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007;4:37–45.PubMedCrossRefGoogle Scholar
  5. 5.
    Aulton ME. Autlon’s pharmaceutics, the design and manufacture of medicines. 3rd ed. Churchill Livingstone; 2007. ISBN: 978-0443101083.Google Scholar
  6. 6.
    Swarbrick J, Boylan JC. Encyclopedia of pharmaceutical technology. 2nd ed. Informa Healthcare; 2002. ISBN: 978-0824728250.Google Scholar
  7. 7.
    Costello I, Long PF, Wong IK, Tuleu C, Yeung V. Paediatric drug handling. 1st ed. Pharmaceutical Press; 2007. ISBN: 978-0853696865.Google Scholar
  8. 8.
    Yaffe SJ, Aranda JV. Neonatal and pediatric pharmacology: therapeutic principles in practice. 3rd ed. Lippincott Williams & Wilkins; 2004. ISBN: 978-0781741859.Google Scholar
  9. 9.
    Ritschel WA, Kearns GL. Handbook of basic pharmacokinetics—including clinical applications. 5th ed. American Pharmaceutical Association; 1999. ISBN: 978-0917330735.Google Scholar
  10. 10.
    Moules T, Ramsay J, Hendrick J. The textbook of children’s nursing: part 1. 2nd ed. Nelson Thornes; 1998. ISBN: 978-0748733408.Google Scholar
  11. 11.
    Bray J, Cragg PA, Macknight A, Mills R, Taylor D. Lecture notes on human physiology. 4th ed. Wiley-Blackwell; 1999. ISBN: 978-0865427754.Google Scholar
  12. 12.
    Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA, Abildgaard K, Rasmussen HH, Rasmussen SN. Measurement of gastrointestinal pH and regional transit times in normal children. J Pediatr Gastroenterol Nutr. 1990;11:211–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Nitzan M, Rosenfield Z. Stool sugars and pH in breast-fed neonates. Arc Dis Child. 1977;52:336–7.CrossRefGoogle Scholar
  14. 14.
    Seidel BM, Schubert S, Schulze B, Borte M. Secretory IgA, free secretory component and IgD in saliva of newborn infants. Early Hum Dev. 2001;62:159–64.PubMedCrossRefGoogle Scholar
  15. 15.
    Lopez ME, Colloca ME, Paez RG, Schallmach JN, Koss MA, Chervonagura A. Salivary characteristics of diabetic children. Braz Dent J. 2003;14:26–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Martins-Gomes AM, Nicolau J, de Souza DN, Oliveira E. A study of some parameters in stimulated saliva from adolescents with dental fluorosis. J Oral Sci. 2001;43:225–31.PubMedGoogle Scholar
  17. 17.
    Guyton AC, Hall JE. Textbook of medical physiology. 11th ed. Saunders; 2005. ISBN: 978-0721602400.Google Scholar
  18. 18.
    Ramaiah RN, Stevenson M, McCallion WA. Hypopharyngeal and distal esophageal pH monitoring in children with gastroesophageal reflux and respiratory symptoms. J Pediatr Surg. 2005;40:1557–61.PubMedCrossRefGoogle Scholar
  19. 19.
    Kato S, Fujimura S, Kimura K, Nishio T, Hamada S, Minoura T, Oda M. Non-helicobacter bacterial flora rarely develops in the gastric mucosal layer of children. Dig Dis Sci. 2006;51:641–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Robinson PJ, Smith AL, Sly PD. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig Dis Sci. 1990;35:1299–304.PubMedCrossRefGoogle Scholar
  21. 21.
    Gray V, Dressman J. Change of pH requirements for simulated intestinal fluid TS. Pharm Forum. 1996;22:1943–5.Google Scholar
  22. 22.
    de Perez la Cruz Moreno M, Oth M, Deferme S, Lammert F, Tack J, Dressman J, Augustijns P. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol. 2006;58:1079–89.CrossRefGoogle Scholar
  23. 23.
    Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull. 1999;46:183–96.PubMedGoogle Scholar
  24. 24.
    Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16:351–80.PubMedCrossRefGoogle Scholar
  25. 25.
    Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10:1093–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Enck P, Zimmermann K, Rusch K, Schwiertz A, Klosterhalfen S, Frick JS. The effects of maturation on the colonic microflora in infancy and childhood. Gastroenterol Res Pract. 2009. Article ID 752401.Google Scholar
  27. 27.
    Jantzen JAH, Tzanova I, Witton PK, Klein AM. Rectal pH in children. Can J Anaesth. 1989;36:665–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Böttger WM, Schoonen BJM, Moolenaar F, Visser F, Meijer DKF. A study on the buffering activity of the human rectum. In vivo demonstration of HCO3- and H+ secretion after rectal application of fluids with an unphysiological pH. Pharm Weekbl Sci. 1989;11:9–12.PubMedGoogle Scholar
  29. 29.
    Thomson ABR, Shaffer EA. First principles of gastroenterology: the basis of disease and the approach to management. 5th ed. Janssen-Ortho; 2000. ISBN: 978-0920163184.Google Scholar
  30. 30.
    Walker R, Edwards C. Clinical pharmacy and therapeutics. 3rd ed. Churchill Livingstone. 2002. ISBN: 978-0443071379.Google Scholar
  31. 31.
    European Medicines Agency (EMEA). Reflection paper: formulations of choice for the paediatric population. 2006;EMEA/CHMP/PEG/194810/2005.Google Scholar
  32. 32.
    ICRP. Basic atomical and physiological data for use in radiological protection: reference values. ICRP publication 89, Ann. ICRP. 2003;32:2–3.Google Scholar
  33. 33.
    Bowles A, Keane J, Ernest T, Clapham D, Tuleu C. Specific aspects of gastro-intestinal transit in children for drug delivery design. Int J Pharm. 2010;395:37–43.PubMedCrossRefGoogle Scholar
  34. 34.
    Dezan CC, Nicolau J, Souza DN, Walter LR. Flow rate, amylase activity, and protein and sialic acid concentrations of saliva from children aged 18, 30 and 42 months attending a baby clinic. Arch Oral Biol. 2002;47:423–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Rodrigues Santos MT, Siqueira WL, Nicolau J. Amylase and peroxidase activities and sialic acid concentration in saliva of adolescents with cerebral palsy. Quintessence Int. 2007;38:467–72.PubMedGoogle Scholar
  36. 36.
    Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH. Quantitative study of salivary secretion in Parkinson’s disease. Mov Disord. 2006;21:660–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Aydin S. A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics. J Biochem Mol Biol. 2007;40:29–35.PubMedGoogle Scholar
  38. 38.
    Weaver LT, Austin S, Cole TJ. Small intestine length: a factor essential for gut adaptation. Gut. 1991;32:1321–3.PubMedCrossRefGoogle Scholar
  39. 39.
    Van Bel F, Van Zwieten PH, Guit GL, Schipper J. Superior mesenteric artery blood flow velocity and estimated volume flow: duplex Doppler US study of preterm and term neonates. Radiology. 1990;174:165–9.PubMedGoogle Scholar
  40. 40.
    Ertem D, Tüney D, Baloglu H, Pehlivanoglu E. Superior mesenteric artery blood flow in children with celiac disease. J Pediatr Gastroenterol Nutr. 1998;26:140–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Qamar MI, Read AE, Skidmore R, Evans JM, Wells PN. Transcutaneous doppler ultrasound measurement of superior mesenteric artery blood flow in man. Gut. 1986;27:100–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.GlaxoSmithKline PharmaceuticalsHarlow, EssexUK

Personalised recommendations